(R)-Oxiracetam - CAS 68252-28-8
Catalog number: 68252-28-8
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
(R)-Oxiracetam is the (R)-enantiomer of the nootropic drug oxiracetam, which is a nootropic drug of the racetam family and stimulant. It is safe even when high doses are consumed for a long period of time, but it is not approved by Food and Drug Administration for any medical use in the United States.
Publictions citing BOC Sciences Products
  • >> More
1.Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry.
Son J1, Lee J, Lee M, Lee E, Lee JH, La S, Kim DH. J Pharm Biomed Anal. 2004 Nov 15;36(3):657-61.
A rapid and accurate reversed-phase liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for the quantitative determination of oxiracetam in human plasma. Oxiracetam, a highly polar compound, was successfully retained by Atlantis dC18 reversed-phase column and detected with triple-quadrupole tandem mass spectrometry. After addition of internal standard (piracetam) to human plasma, plasma was simply precipitated with two volume of acetonitrile, evaporated and dissolved in 0.1% acetic acid. This method for the determination of oxiracetam was accurate and reproducible, with a limit of quantitation of 0.2microg/ml in human plasma. The standard calibration curve for oxiracetam was linear (r(2) = 0.999) over the concentration range 0.2-40.0microg/ml in human plasma. The intra- and inter-day precision over the concentration range of oxiracetam was lower than 8.3% (relative standard deviation, %R.S.D.
2.Calcium entry blockers and oxiracetam have opposite effects on the density of dihydropyridine receptors in rat cerebral cortex.
Dudkin SM1, Polev PV, Soldatov NM. Brain Res. 1990 Aug 20;525(2):319-21.
Ca2+ entry blockers riodipine, D-cis-diltiazem and verapamil, when administered i.p. to rats at a dose of 10 mg/kg, produced two-fold decreases in the density of 1,4-dihydropyridine (DHP) receptors in rat cerebral cortex, as revealed by Scatchard plot analysis of radioligand binding made 24 h after the first injection. Thereafter, the number of DHP binding sites increased up to the initial level on day 4 of the treatment. The nootropic drug oxiracetam, when injected simultaneously with Ca2+ channel blockers at a dose of 10 mg/kg, prevented this transient decrease in DHP receptor density in brain. These results can explain the opposite modulation of memory retention by calcium antagonists and nootropic drugs that has been observed previously.
3.Effects of nootropic drugs in a scopolamine-induced amnesia model in mice.
Verloes R1, Scotto AM, Gobert J, Wülfert E. Psychopharmacology (Berl). 1988;95(2):226-30.
Scopolamine (3 mg/kg IP) given before an acquisition trial, reduced the retention of a one-trial passive avoidance "step through" response in mice. A single administration of cholinergic agonists such as oxotremorine, BM-5, or arecoline, antagonized this amnesic effect of scopolamine. A significant anti-amnesic effect was also found with nootropic drugs such as piracetam and ucb L059, whereas ucb L060 (the enantiomer of ucb L059), oxiracetam and rolziracetam were shown to be ineffective. Moreover, ucb L059, administered twice daily for 3 days, counteracted the amnesic effects of scopolamine completely, whereas ucb L060 was again inactive. The results demonstrate that: (a) this model of impaired cognition by scopolamine is able to discriminate between closely related chemical substances and even stereoisomers; and (b) nootropic drugs, such as ucb L059, are more effective after repeated rather than after acute administration.
4.Glycosides of cistanche improve learning and memory in the rat model of vascular dementia.
Chen J1, Zhou SN, Zhang YM, Feng YL, Wang S. Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1234-40.
OBJECTIVE: Glycosides of cistanche (GC) is extracted from Xin Jiang Cistanche, which is widely used as a Chinese herb. This study aims to evaluate the effects of GC on vascular dementia (VD).
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 115103-54-3 Tiagabine

(CAS: 115103-54-3)

Tiagabine is a selective gamma-aminobutyric acid (GABA) reuptake inhibitor.

(CAS: 872599-83-2)

Epelsiban is an oxytocin receptor antagonist under the developement of GlaxoSmithKline. It has high affinity for the oxytocin receptor (Ki = 0.13 nM) with >31,0...

(CAS: 911714-45-9)

SP-420 is a desferrithiocin analogue with iron-clearing efficiency. Its ICE value is 26.7. It is more potent than desferrithiocin.

CAS 479-41-4 Indirubin

(CAS: 479-41-4)

Indirubin is an inhibitor of GSK-3β and of cyclin-dependent kinases (CDK1/cyclin B, CDK2/cyclin A, CDK2/cyclin E, CDK4/cyclin D1, CDK5/p35). Also, indirubin is ...

CAS 65-19-0 Yohimbine HCl

Yohimbine HCl
(CAS: 65-19-0)

Yohimbine, an indole alkaloid derived from the bark of the Pausinystalia yohimbe tree in Central Africa, has been used as a mydriatic and in the treatment of im...

(CAS: 103828-82-6)

LY-223592 is a bio-active chemical compound. It has antitumor activity. It was developed by Eli Lilly & Co.

CAS 1434635-54-7 ND-630

(CAS: 1434635-54-7)

ND-630, also called as NDI 010976, is a highly selective, reversible inhibitor of acetyl-CoA carboxylase (ACC) and had IC50 values of 2 and 7 nM for ACC1 and 2,...

CAS 53936-56-4 Deoxyarbutin

(CAS: 53936-56-4)

DeoxyArbutin is a reversible tyrosinase inhibitor, inhibiting tyrosinase activity with IC50 of 50 nM.

CAS 134418-28-3 Dehydroandrographolide

(CAS: 134418-28-3)

Dehydroandrographolide is a natural diterpenoid found in Andrographis paniculata. It possesses activity against hepatitis B virus DNA replication.

MK 1-907
(CAS: 78150-06-8)

MK-1-907 is a centrally acting drug, but no detailed information has been published yet.

Dalasetron Mesylate hydrate
(CAS: 878143-33-0)

Dalasetron Mesylate hydrate is a serotonin 5-HT3 receptor antagonist. It is used to treat nausea and vomiting following chemotherapy.

CAS 163451-81-8 Teriflunomide

(CAS: 163451-81-8)

Teriflunomide, the active metabolite of leflunomide, is an immunomodulatory drug inhibiting pyrimidine de novo synthesis by blocking the enzyme dihydroorotate d...

CAS 56124-62-0 Valrubicin

(CAS: 56124-62-0)

Valrubicin (AD-32) is a chemotherapy drug used to treat bladder cancer. It is a semisynthetic analog of the anthracycline doxorubicin, and is administered by in...

(CAS: 186139-09-3)

Trodusquemine, also called as MSI-1436 or Aminosterol-1436, with the potential to treat type 2 diabetes and obesity, it is a non-competitive cholestane inihbito...

CAS 6501-72-0 GIT 27

GIT 27
(CAS: 6501-72-0)

Interferes with TLR4, TLR2/6 signaling; Orally active immunomodulatory agent; Inhibits TNF-α secretion via interference of macrophage TLR4 and TLR 2/6 signaling...

CAS 74397-12-9 Limaprost

(CAS: 74397-12-9)

Limaprost is a potent platelet adhesion inhibitor and vasodilator that increases blood flow and inhibits platelet aggregation. It is an analog of prostaglandin ...

CAS 2901-75-9 N-Acetyl-DL-phenylalanine

(CAS: 2901-75-9)

N-Acetyl-DL-phenylalanine is a drug to treat depression.

CAS 51011-05-3 6''-O-Malonylgenistin

(CAS: 51011-05-3)

6''-O-Malonylgenistin (Malonylgenistin) is an isoflavone derivative.

CAS 58821-95-7 Tinyatoxin

(CAS: 58821-95-7)

Tinyatoxin is a neurotoxin, acting via vanilloid receptors of sensory nerves.

CAS 4754-39-6 Deoxyadenosine

(CAS: 4754-39-6)

Deoxyadenosine is a substrate of bacterial methylthioadenosine/S-adenosylhomocysteine (MTA/SAH) nucleosidase and a product inhibitor produced by radical SAM enz...

Chemical Structure

CAS 68252-28-8 (R)-Oxiracetam

Quick Inquiry

Verification code

Featured Items